The increasing prevalence of cardiac disorders in the U.S., especially arrhythmias such as atrial fibrillation, heart block, and ventricular tachycardia, is a key driver for the electrophysiology equipment market. With rising rates of lifestyle-related conditions like hypertension, diabetes, and obesity, the incidence of heart rhythm disorders has surged in recent years. This growing burden on the healthcare system necessitates the use of advanced diagnostic and therapeutic tools, such as electrophysiology devices, to effectively diagnose, monitor, and treat these conditions. As more patients seek treatments like catheter ablation and other electrophysiology procedures to manage their conditions, the demand for high-performance EP equipment increases, driving both innovation and adoption within the market. This rise in demand for effective treatment options directly propels market growth, making the increasing prevalence of cardiac disorders a crucial driver for the electrophysiology equipment sector.
Access Full Report @ https://www.databridgemarketresearch.com/pt/reports/us-electrophysiology-equipment-market
Data Bridge Market Research analyzes that the U.S. Electrophysiology Equipment Market is expected to reach USD 9.60 billion by 2032 from USD 5.08 billion in 2024, growing at a CAGR of 8.3% in the forecast period of 2025 to 2031.
Key Findings of the Study
Growing Number of Catheter Ablation Procedures
The growing number of catheter ablation procedures significantly creates opportunities for the U.S. electrophysiology equipment market by increasing the demand for advanced diagnostic and therapeutic devices. Catheter ablation, primarily used for treating arrhythmias, such as atrial fibrillation and ventricular tachycardia, is a minimally invasive procedure that offers advantages over traditional methods, such as medication management or surgical interventions. As awareness about the benefits of catheter ablation rises among patients and healthcare providers, and as more healthcare facilities adopt these technologies, the demand for electrophysiology equipment such as catheters, mapping systems, and electrophysiology analyzers rise. This trend is further supported by a growing aging population, which is more prone to cardiovascular diseases requiring such interventions.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2025 to 2032
|
|
Base Year
|
2024
|
|
Historic Year
|
2023 (Customizable 2013-2017)
|
|
Quantitative Units
|
Revenue in USD Billion
|
|
Segments Covered
|
Type (Ablation Catheters, Electrophysiology Laboratory Equipment, Diagnostic Catheters, Access Devices, and Others), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia(AVNRT), Wolff-Parkinson-White Syndrome (WPW), and Others), Function (Advanced, Conventional, Cryoablation, and Others), Procedure (Ventricular Fibrillation, Tumor Ablation, Single-Position Non-Contact Mapping, Multipoint Electroanatomic Mapping for Simple Arrhythmias, Varicose Veins, and Others), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cardiac Catheterization Laboratories, Speciality Clinics, and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Market Players Covered
|
Johnsons & Johnsons(U.S.), Abbott(U.S.), Medtronic(Dublin, Ireland) , Boston Scientific Corporation(U.S.), and Koninklijke Philips N.V.(U.S.) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The U.S. electrophysiology equipment market markets segmented into six notable segments the basis of type, by indication, by function, by procedure, by end user and by distribution channel.
- On the basis of type, the market is segmented into ablation catheters, electrophysiology laboratory equipment, diagnostic catheters, access devices, and others
In 2025, the ablation catheters segment is expected to dominate the market with a market share of 46.73%
In 2025, the ablation catheters segment is expected to dominate the market with a market share of 46.73% due to their effectiveness in treating arrhythmias through minimally invasive procedures, enhancing patient outcomes and reducing recovery times.
- On the basis of indication, the market is segmented into atrial fibrillation, atrial flutter, Atrioventricular Nodal Reentry Tachycardia(AVNRT), Wolff-Parkinson-White Syndrome (WPW), and others
In 2025, the atrial fibrillation segment is expected to dominate the market with a market share of 46.19%
In 2025, the atrial fibrillation segment is expected to dominate the market with a market share of 46.19% due to its high prevalence among the aging population and the increasing demand for effective treatment options to manage this common cardiac arrhythmia.
- On the basis of function, the market is segmented into advanced, conventional, cryoablation, and others. In 2025, the advanced segment is expected to dominate the market with a market share of 42.11%
- On the basis of procedure, the market is segmented into ventricular fibrillation, tumor ablation, single-position non-contact mapping, multipoint electroanatomic mapping for simple arrhythmias varicose veins, and others. In 2025, the ventricular fibrillation segment is expected to dominate the market with a market share of 30.76%
- On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, cardiac catheterization laboratories, speciality clinics, and others. In 2025, the Hospitals segment is expected to dominate the market with a market share of 53.23%
- On the basis of distribution channel, the market is segmented into direct tender and retail sales. In 2025, the direct tender segment is expected to dominate the market with a market share of 61.51%
Major Players
Data Bridge Market Research analyzes Johnsons & Johnsons(U.S.), Abbott(U.S.), Medtronic(Dublin, Ireland), Boston Scientific Corporation(U.S.), Koninklijke Philips N.V.(U.S) as major market players.
Market Development
- In November 2024, GE HealthCare announced an initiative with AMN Healthcare to address the shortage of radiologic technologists. The collaboration combined AMN's workforce solutions with GE's technology and training to help healthcare providers meet staffing needs and improve patient care
- In November 2024, Boston Scientific announced the completion of its acquisition of Axonics, Inc., a leader in devices for urinary and bowel dysfunction. This acquisition expands Boston Scientific’s Urology portfolio, enhancing its offerings in sacral neuromodulation and tailored treatments for incontinence
- In October 2024, Teleflex Incorporated has launched two new devices in Canada to enhance PICC insertion procedures: the next-generation Arrow VPS Rhythm DLX Device and NaviCurve Stylet. These devices work together to improve the efficiency and predictability of PICC placement. The VPS Rhythm DLX Device provides real-time catheter tip location information using cardiac electrical activity and includes an optional integrated ultrasound for standardized vessel measurement. This launch will help Teleflex strengthen its presence in the vascular access market and improve patient outcomes through advanced technology.
- In October 2024, Medtronic announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter for treating persistent atrial fibrillation (AFib) and atrial flutter. With this approval, Medtronic becomes the first to offer two PFA technologies, enhancing treatment flexibility for physicians
- In April 2022, AtriCure has launched the EnCompass Clamp in the U.S., part of its Isolator Synergy Ablation System. FDA-cleared for cardiac tissue ablation during surgery, the clamp features magnetic guidance, parallel closure, and custom power for more efficient procedures with minimal tissue dissection, enhancing surgical outcomes for Afib treatments
As per Data Bridge Market Research analysis:
For more detailed information about the U.S. electrophysiology equipment market Market report, click here – https://www.databridgemarketresearch.com/pt/reports/us-electrophysiology-equipment-market
